World health organization guidelines on medicines for diabetes treatment intensification: Commentary from the American college of physicians high value care committee

High Value Care Committee of the American College of Physicians

doi:10.7326/M18-1148

World health organization guidelines on medicines for diabetes treatment intensification: Commentary from the American college of physicians high value care committee

High Value Care Committee of the American College of Physicians

Medical Informatics & Clinical Epidemiology

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Original language	English (US)
Pages (from-to)	398-400
Number of pages	3
Journal	Annals of internal medicine
Volume	169
Issue number	6
DOIs	https://doi.org/10.7326/M18-1148
State	Published - Sep 18 2018

ASJC Scopus subject areas

Internal Medicine

Access to Document

10.7326/M18-1148

Cite this

World health organization guidelines on medicines for diabetes treatment intensification : Commentary from the American college of physicians high value care committee. / High Value Care Committee of the American College of Physicians.

In: Annals of internal medicine, Vol. 169, No. 6, 18.09.2018, p. 398-400.

Research output: Contribution to journal › Article › peer-review

@article{b2040fad161a4a0bb722fada6e11e995,

title = "World health organization guidelines on medicines for diabetes treatment intensification: Commentary from the American college of physicians high value care committee",

author = "{High Value Care Committee of the American College of Physicians} and Humphrey, {Linda L.} and Devan Kansagara and Amir Qaseem and Amir Qaseem and Abraham, {George M.} and Robert Centor and DeLong, {Douglas M.} and Gantzer, {Heather E.} and Horwitch, {Carrie A.} and Humphrey, {Linda L.} and Jokela, {Janet A.} and Li, {Joseph Ming Wah} and Lohr, {Robert H.} and L{\'o}pez, {Ana Mar{\'i}a} and McLean, {Robert M.}",

note = "Funding Information: Financial Support: Financial support for the development of this commentary comes exclusively from the ACP operating budget.",

year = "2018",

month = sep,

day = "18",

doi = "10.7326/M18-1148",

language = "English (US)",

volume = "169",

pages = "398--400",

journal = "Annals of Internal Medicine",

issn = "0003-4819",

publisher = "American College of Physicians",

number = "6",

}

TY - JOUR

T1 - World health organization guidelines on medicines for diabetes treatment intensification

T2 - Commentary from the American college of physicians high value care committee

AU - High Value Care Committee of the American College of Physicians

AU - Humphrey, Linda L.

AU - Kansagara, Devan

AU - Qaseem, Amir

AU - Abraham, George M.

AU - Centor, Robert

AU - DeLong, Douglas M.

AU - Gantzer, Heather E.

AU - Horwitch, Carrie A.

AU - Humphrey, Linda L.

AU - Jokela, Janet A.

AU - Li, Joseph Ming Wah

AU - Lohr, Robert H.

AU - López, Ana María

AU - McLean, Robert M.

N1 - Funding Information: Financial Support: Financial support for the development of this commentary comes exclusively from the ACP operating budget.

PY - 2018/9/18

Y1 - 2018/9/18

UR - http://www.scopus.com/inward/record.url?scp=85053503116&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053503116&partnerID=8YFLogxK

U2 - 10.7326/M18-1148

DO - 10.7326/M18-1148

M3 - Article

AN - SCOPUS:85053503116

SN - 0003-4819

VL - 169

SP - 398

EP - 400

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

IS - 6

ER -

World health organization guidelines on medicines for diabetes treatment intensification: Commentary from the American college of physicians high value care committee

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this